Nomogram-based risk prediction of macrosomia: a case-control study

BMC Pregnancy Childbirth. 2022 May 5;22(1):392. doi: 10.1186/s12884-022-04706-y.

Abstract

Background: Macrosomia is closely associated with poor maternal and fetal outcome. But there is short of studies on the risk of macrosomia in early pregnancy. The purpose of this study is to establish a nomogram for predicting macrosomia in the first trimester.

Methods: A case-control study involving 1549 pregnant women was performed. According to the birth weight of newborn, the subjects were divided into macrosomia group and non-macrosomia group. The risk factors for macrosomia in early pregnancy were analyzed by multivariate logistic regression. A nomogram was used to predict the risk of macrosomia.

Results: The prevalence of macrosomia was 6.13% (95/1549) in our hospital. Multivariate logistic regression analysis showed that prepregnancy overweight (OR: 2.13 95% CI: 1.18-3.83)/obesity (OR: 3.54, 95% CI: 1.56-8.04), multiparity (OR:1.88, 95% CI: 1.16-3.04), the history of macrosomia (OR: 36.97, 95% CI: 19.90-68.67), the history of GDM/DM (OR: 2.29, 95% CI: 1.31-3.98), the high levels of HbA1c (OR: 1.76, 95% CI: 1.00-3.10) and TC (OR: 1.36, 95% CI: 1.00-1.84) in the first trimester were the risk factors of macrosomia. The area under ROC (the receiver operating characteristic) curve of the nomogram model was 0.807 (95% CI: 0.755-0.859). The sensitivity and specificity of the model were 0.716 and 0.777, respectively.

Conclusion: The nomogram model provides an effective mothed for clinicians to predict macrosomia in the first trimester.

Keywords: Macrosomia; Nomogram; Risk factor; Screening.

MeSH terms

  • Birth Weight
  • Case-Control Studies
  • Diabetes, Gestational* / epidemiology
  • Female
  • Fetal Macrosomia / epidemiology
  • Fetal Macrosomia / etiology
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases*
  • Nomograms
  • Pregnancy
  • Risk Factors
  • Weight Gain